RBOT Valuation

Vicarious Surgical Inc

Add to Watchlist

Advanced Chart

6.520

-0.34(-4.956%)1D

Overview
Forecast
Valuation
Earnings

RBOT Relative Valuation

RBOT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RBOT is overvalued; if below, it's undervalued.

Historical Valuation

Vicarious Surgical Inc (RBOT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.03. The fair price of Vicarious Surgical Inc (RBOT) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：6.86

Fair

-0.88

Trailing

Forward

-1.02

EV/EBITDA

Vicarious Surgical Inc. (RBOT) has a current EV/EBITDA of -1.02. The 5-year average EV/EBITDA is -3.17. The thresholds are as follows: Strongly Undervalued below -15.46, Undervalued between -15.46 and -9.32, Fairly Valued between 2.98 and -9.32, Overvalued between 2.98 and 9.12, and Strongly Overvalued above 9.12. The current Forward EV/EBITDA of -1.02 falls within the Historic Trend Line -Fairly Valued range.

-0.54

EV/EBIT

Vicarious Surgical Inc. (RBOT) has a current EV/EBIT of -0.54. The 5-year average EV/EBIT is -3.09. The thresholds are as follows: Strongly Undervalued below -15.49, Undervalued between -15.49 and -9.29, Fairly Valued between 3.10 and -9.29, Overvalued between 3.10 and 9.30, and Strongly Overvalued above 9.30. The current Forward EV/EBIT of -0.54 falls within the Historic Trend Line -Fairly Valued range.

0.00

Vicarious Surgical Inc. (RBOT) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

0.00

P/OCF

Vicarious Surgical Inc. (RBOT) has a current P/OCF of 0.00. The 5-year average P/OCF is -3.64. The thresholds are as follows: Strongly Undervalued below -22.56, Undervalued between -22.56 and -13.10, Fairly Valued between 5.82 and -13.10, Overvalued between 5.82 and 15.28, and Strongly Overvalued above 15.28. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Vicarious Surgical Inc. (RBOT) has a current P/FCF of 0.00. The 5-year average P/FCF is -3.34. The thresholds are as follows: Strongly Undervalued below -19.00, Undervalued between -19.00 and -11.17, Fairly Valued between 4.48 and -11.17, Overvalued between 4.48 and 12.31, and Strongly Overvalued above 12.31. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Vicarious Surgical Inc (RBOT) has a current Price-to-Book (P/B) ratio of 1.77. Compared to its 3-year average P/B ratio of 1.68 , the current P/B ratio is approximately 5.36% higher. Relative to its 5-year average P/B ratio of 3.07, the current P/B ratio is about -42.46% higher. Vicarious Surgical Inc (RBOT) has a Forward Free Cash Flow (FCF) yield of approximately -112.48%. Compared to its 3-year average FCF yield of -75.77%, the current FCF yield is approximately 48.45% lower. Relative to its 5-year average FCF yield of -59.27% , the current FCF yield is about 89.78% lower.

1.77

P/B

Median3y

1.68

Median5y

3.07

-112.48

FCF Yield

Median3y

-75.77

Median5y

-59.27

Competitors Valuation Multiple

The average P/S ratio for RBOT's competitors is 3.06, providing a benchmark for relative valuation. Vicarious Surgical Inc Corp (RBOT) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

RBOT.N

Vicarious Surgical Inc

NeuroOne Medical Technologies Corp

X T L Biopharmaceuticals Ltd

0.04

1.24B

WOK.O

Work Medical Technology Group Ltd

Loss

43.61M

Performance Decomposition

Market capitalization of RBOT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of RBOT in the past 1 year is driven by Unknown.